HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Combination of 2'-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice.

AbstractBACKGROUND:
A critical role for host-microbe interactions and establishment of vaccine responses has been postulated. Human milk oligosaccharides, of which 2'-fucosyllactose (2'FL) is the most prevalent, are known to alter host-associated microbial communities and play a critical role in the immunologic development of breastfed infants.
OBJECTIVES:
Dietary supplementation with a combination of 2'FL and prebiotic short-chain (sc) galacto-oligosaccharides (GOS) and long-chain (lc) fructo-oligosaccharides (FOS) was employed to examine human milk oligosaccharide effects on immune responsiveness, within a murine influenza vaccination model.
METHODS:
Female mice (6 wk old, C57Bl/6JOlaHsd) were fed either control diet (CON) or scGOS/lcFOS/2'FL-containing diet (GF2F) for 45 d. After starting dietary intervention (day 14), mice received a primary influenza vaccination (day 0) followed by a booster vaccination (day 21), after which ear challenges were conducted to measure vaccine-specific delayed type hypersensitivity (DTH). Serum immunoglobulin (Ig) levels, fecal and cecal microbial community structure, short-chain fatty acids, host intestinal gene expression and cellular responses in the mesenteric lymph nodes (MLNs) were also measured.
RESULTS:
Relative to CON, mice fed the GF2F diet had increased influenza vaccine-specific DTH responses (79.3%; P < 0.01), higher levels of both IgG1 (3.2-fold; P < 0.05) and IgG2a (1.2-fold; P < 0.05) in serum, and greater percentages of activated B cells (0.3%; P < 0.05), regulatory T cells (1.64%; P < 0.05), and T-helper 1 cells (2.2%; P < 0.05) in their MLNs. GF2F-fed mice had elevated cecal butyric (P < 0.05) and propionic (P < 0.05) acid levels relative to CON, which correlated to DTH responses (R2 = 0.22; P = 0.05 and R2 = 0.39; P < 0.01, respectively). Specific fecal microbial taxa altered in GF2F diet fed mice relative to CON were significantly correlated with the DTH response and IgG2a level increases.
CONCLUSIONS:
Dietary GF2F improved influenza vaccine-specific T-helper 1 responses and B cell activation in MLNs and enhanced systemic IgG1 and IgG2a concentrations in mice. These immunologic changes are correlated with microbial community structure and metabolites.
AuthorsLing Xiao, Phillip A Engen, Thea Leusink-Muis, Ingrid van Ark, Bernd Stahl, Saskia A Overbeek, Johan Garssen, Ankur Naqib, Stefan J Green, Ali Keshavarzian, Gert Folkerts, Belinda Van't Land
JournalThe Journal of nutrition (J Nutr) Vol. 149 Issue 5 Pg. 856-869 (05 01 2019) ISSN: 1541-6100 [Electronic] United States
PMID31050747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © American Society for Nutrition 2019.
Chemical References
  • Immunoglobulin G
  • Immunologic Factors
  • Influenza Vaccines
  • Oligosaccharides
  • Prebiotics
  • Trisaccharides
  • Fructose
  • Galactose
  • 2'-fucosyllactose
Topics
  • Animals
  • B-Lymphocytes
  • Cecum (metabolism, microbiology)
  • Colon (metabolism, microbiology)
  • Feces (microbiology)
  • Female
  • Fructose (pharmacology, therapeutic use)
  • Galactose (pharmacology, therapeutic use)
  • Humans
  • Immunoglobulin G (blood)
  • Immunologic Factors (pharmacology, therapeutic use)
  • Influenza Vaccines
  • Influenza, Human (immunology, prevention & control)
  • Mice, Inbred C57BL
  • Milk, Human (chemistry)
  • Mucous Membrane (drug effects, immunology)
  • Oligosaccharides (pharmacology, therapeutic use)
  • Prebiotics
  • Th1 Cells
  • Trisaccharides (pharmacology, therapeutic use)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: